XML 21 R48.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Y
Dec. 31, 2010
Y
Dec. 31, 2009
Y
Dec. 31, 2008
Y
Stock option activity        
Options outstanding at the beginning of the period (in shares) 12,706,324 12,704,303 11,229,837  
Options granted (in shares) 2,551,350 2,602,500 3,736,500  
Options exercised (in shares) (1,037,674) (2,331,429) (2,029,874)  
Options forfeited (in shares) (203,100) (269,050) (232,160)  
Options outstanding at the end of the period (in shares) 14,016,900 12,706,324 12,704,303  
Vested and non-vested expected to vest at the end of the period (in shares) 13,066,583      
Exercisable at the end of the period (in shares) 6,380,324      
Weighted Average Exercise Price        
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) $ 33.93 $ 29.58 $ 25.82  
Weighted average exercise price, options granted (in dollars per share) $ 53.45 $ 43.00 $ 32.01  
Weighted average exercise price, options exercised (in dollars per share) $ 25.14 $ 19.99 $ 12.55  
Weighted average exercise price, options forfeited (in dollars per share) $ 39.75 $ 37.18 $ 35.89  
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) $ 38.00 $ 33.93 $ 29.58  
Weighted average exercise price, vested and non-vested expected to vest (in dollars per share) $ 37.57      
Weighted average exercise price, exercisable (in dollars per share) $ 31.48      
Weighted Average Remaining Contractual Term        
Weighted average remaining contractual term of options outstanding (in years) 6.89 7.18 7.16 6.69
Weighted average remaining contractual term of options vested and non-vested expected to vest (in years) 6.79      
Weighted average remaining contractual term of options exercisable (in years) 5.41      
Aggregate Intrinsic Value        
Aggregate intrinsic value of options outstanding (in dollars) $ 125,067      
Aggregate intrinsic value of options, vested and non-vested expected to vest (in dollars) 120,850      
Aggregate intrinsic value of options exercisable (in dollars) 89,316      
Status of the Company's non-vested options and changes during the year        
Non-vested options at the beginning of the period (in shares) 7,623,976      
Non-vested options, options granted (in shares) 2,551,350      
Non-vested options, options vested (in shares) (2,335,650)      
Non-vested options, options forfeited (in shares) (203,100)      
Non-vested options at the end of the period (in shares) 7,636,576 7,623,976    
Weighted Average Fair Value at Grant Date        
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) $ 12.78      
Weighted average fair value at grant date, options granted (in dollars per share) $ 14.19 $ 14.69 $ 11.12  
Weighted average fair value at grant date, options vested (in dollars per share) $ 12.23      
Weighted average fair value at grant date, options forfeited (in dollars per share) $ 13.00      
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) $ 13.41 $ 12.78    
Total intrinsic value of stock options exercised (in dollars) 29,697 67,841 56,900  
Total fair value of stock options vested (in dollars) 28,563 23,714 17,360  
Total compensation cost related to non-vested options not yet recognized (in dollars) $ 74,434      
Weighted average expected amortization period (in years) 3.26      
2009 Option Plan
       
Share-based Compensation Arrangement by Share-based Payment Award        
Shares available for the granting of additional stock options (in shares) 7,684,550,000      
2000 Option Plan and 2009 Option Plan
       
Share-based Compensation Arrangement by Share-based Payment Award        
Options ratable vesting period (in years) 5 years      
Options exercisable period (in years) 10 years      
Directors Option Plan
       
Share-based Compensation Arrangement by Share-based Payment Award        
Shares available for the granting of additional stock options (in shares) 80,000      
Options ratable vesting period (in years) 3 years      
Options exercisable period (in years) 10 years